6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Leukemia, Lymphocytic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inanami, O; Kuwabara, M; Takahashi, K | 1 |
1 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Leukemia, Lymphocytic
| Article | Year |
|---|---|
Attenuation of caspase-3-dependent apoptosis by Trolox post-treatment of X-irradiated MOLT-4 cells.
Topics: Antioxidants; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspases; Cell Survival; Chromans; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Fragmentation; G1 Phase; Humans; JNK Mitogen-Activated Protein Kinases; Leukemia, Lymphoid; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Poly(ADP-ribose) Polymerases; Protein Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Tumor Suppressor Protein p53; X-Rays | 1999 |